MRNAModerna, Inc.

Nasdaq modernatx.com


$ 87.16 $ -7.01 (-7.44 %)    

Friday, 02-Aug-2024 13:27:01 EDT
QQQ $ 447.58 $ -4.26 (-0.94 %)
DIA $ 395.01 $ -3.74 (-0.94 %)
SPY $ 530.75 $ -6.54 (-1.22 %)
TLT $ 97.91 $ 0.28 (0.29 %)
GLD $ 224.10 $ -3.91 (-1.71 %)
$ 94.17
$ 92.36
$ 86.51 x 104
$ 170.00 x 205
$ 86.89 - $ 92.64
$ 62.55 - $ 170.47
18,591,903
na
36.16B
$ 0.37
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-01-2024 06-30-2024 10-Q
2 05-02-2024 03-31-2024 10-Q
3 02-23-2024 12-31-2023 10-K
4 11-03-2023 09-30-2023 10-Q
5 08-03-2023 06-30-2023 10-Q
6 05-04-2023 03-31-2023 10-Q
7 02-24-2023 12-31-2022 10-K
8 11-03-2022 09-30-2022 10-Q
9 08-03-2022 06-30-2022 10-Q
10 05-04-2022 03-31-2022 10-Q
11 02-25-2022 12-31-2021 10-K
12 11-04-2021 09-30-2021 10-Q
13 08-05-2021 06-30-2021 10-Q
14 05-06-2021 03-31-2021 10-Q
15 02-26-2021 12-31-2020 10-K
16 10-30-2020 09-30-2020 10-Q
17 08-06-2020 06-30-2020 10-Q
18 05-07-2020 03-31-2020 10-Q
19 02-27-2020 12-31-2019 10-K
20 11-06-2019 09-30-2019 10-Q
21 08-08-2019 06-30-2019 10-Q
22 05-09-2019 03-31-2019 10-Q
23 03-13-2019 12-31-2018 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 goldman-sachs-maintains-buy-on-moderna-lowers-price-target-to-178

Goldman Sachs analyst Salveen Richter maintains Moderna (NASDAQ:MRNA) with a Buy and lowers the price target from $204 to $178.

 barclays-maintains-overweight-on-moderna-lowers-price-target-to-155

Barclays analyst Gena Wang maintains Moderna (NASDAQ:MRNA) with a Overweight and lowers the price target from $168 to $155.

 piper-sandler-reiterates-overweight-on-moderna-lowers-price-target-to-157

Piper Sandler analyst Edward Tenthoff reiterates Moderna (NASDAQ:MRNA) with a Overweight and lowers the price target from $2...

 cathie-woods-ark-adds-over-19m-worth-of-moderna-shares-after-thursdays-21-plunge-on-guidance-cut

Moderna's vaccine magic is slowly losing its charm, as evidenced by the warning the company issued on Thursday but Ark repo...

 us-stocks-close-lower-as-apple-amazon-report-earnings-greed-index-moves-to-fear-zone

The CNN Fear and Greed index fell to 39.6, signaling Fear in the market. Dow Jones dropped 495 points, Nasdaq down 2.3%, S&...

 needham-reiterates-hold-on-moderna

Needham analyst Joseph Stringer reiterates Moderna (NASDAQ:MRNA) with a Hold.

 stock-of-the-day-moderna-stock-plunges-breaking-key-support-levels-following-earnings-report

Shares of Moderna (MRNA) have broken an important support level. This means a new downtrend may be forming.

 moderna-stock-sinks-on-lowered-2024-outlook-cites-low-european-sales-competitive-rsv-vaccine-market

Moderna's stock drops after cutting 2024 sales forecast due to reduced COVID-19 vaccine demand. The company now expects net...

Core News & Articles

- Conference Call

 moderna-revises-its-2024-expected-net-product-sales-to-3b-35b-from-its-respiratory-franchise-compared-to-prior-guidance-of-4b

For the second half of the year, it expects a sales split of 40-50% in the third quarter with the balance in the fourth quarter...

Core News & Articles

Directors Robert Langer and Stephen Berenson will also retire from the Board.

 covid-activity-is-elevated-across-26-states-in-summer-surge-biden-remains-in-isolation-3-vaccine-stocks-to-watch

Over half of US states have high levels of Covid-19 in wastewater as President Biden isolates with virus. New vaccines expected...

 european-commission-faces-court-criticism-over-covid-vaccine-contract-transparency-ahead-of-vote-on-ursula-von-der-leyens-reappointment

European Commission faces scrutiny over COVID vaccine contract transparency ahead of key vote. Legal challenges and implication...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION